Robert E Davis - Net Worth and Insider Trading
Robert E Davis Net Worth
The estimated net worth of Robert E Davis is at least $4 Million dollars as of 2024-05-25. Robert E Davis is the SVP, Chief Scientific Officer of Intra-Cellular Therapies Inc and owns about 43,989 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $3 Million. Robert E Davis is also the Executive VP of Drug Discovery of ACADIA Pharmaceuticals Inc and owns about 105,500 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $2 Million. Details can be seen in Robert E Davis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert E Davis has not made any transactions after 2019-01-04 and currently still holds the listed stock(s).
Transaction Summary of Robert E Davis
Robert E Davis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert E Davis owns 2 companies in total, including Intra-Cellular Therapies Inc (ITCI) , and ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of Robert E Davis’s form 4 insider trades.
Insider Ownership Summary of Robert E Davis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2019-01-04 | SVP & Chief Scientific Officer |
| ACAD | ACADIA Pharmaceuticals Inc | 2004-05-26 | Executive VP of Drug Discovery |
Robert E Davis Latest Holdings Summary
Robert E Davis currently owns a total of 2 stocks. Among these stocks, Robert E Davis owns 43,989 shares of Intra-Cellular Therapies Inc (ITCI) as of January 4, 2019, with a value of $3 Million and a weighting of 64.26%. Robert E Davis also owns 105,500 shares of ACADIA Pharmaceuticals Inc (ACAD) as of May 26, 2004, with a value of $2 Million and a weighting of 35.74%.
Latest Holdings of Robert E Davis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2019-01-04 | 43,989 | 65.54 | 2,883,039 |
| ACAD | ACADIA Pharmaceuticals Inc | 2004-05-26 | 105,500 | 15.20 | 1,603,600 |
Holding Weightings of Robert E Davis
Robert E Davis Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert E Davis has made a total of 0 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 9,564 shares on January 4, 2019, which brought Robert E Davis around $109,603.
According to the SEC Form 4 filings, Robert E Davis has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 0 shares on May 26, 2004, which brought Robert E Davis around $0.
Insider Trading History of Robert E Davis
- 1
Robert E Davis Trading Performance
Robert E Davis Ownership Network
Robert E Davis Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Robert E Davis is the SVP & Chief Scientific Officer of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include EVP & Chief Commercial Officer Mark Neumann , Chief Medical Officer Suresh K. Durgam , and director & Chairman & President & CEO Sharon Mates .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Robert E Davis made no insider transaction in Intra-Cellular Therapies Inc (ITCI). Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 181,034 shares made by Mark Neumann , a net sale of 554,970 shares made by Sharon Mates , and a net sale of 233,341 shares made by Michael Halstead .
In summary, during the past 3 months, insiders sold 237,827 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 237,827 shares. During the past 18 months, 1,382,842 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,382,842 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Robert E Davis Mailing Address
Above is the net worth, insider trading, and ownership report for Robert E Davis. You might contact Robert E Davis via mailing address: 3911 Sorrento Valley Boulevard, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
